WO2002004672A3 - Diagnostic method for the identification of foetal dna in a maternal sample - Google Patents

Diagnostic method for the identification of foetal dna in a maternal sample Download PDF

Info

Publication number
WO2002004672A3
WO2002004672A3 PCT/GB2001/003092 GB0103092W WO0204672A3 WO 2002004672 A3 WO2002004672 A3 WO 2002004672A3 GB 0103092 W GB0103092 W GB 0103092W WO 0204672 A3 WO0204672 A3 WO 0204672A3
Authority
WO
WIPO (PCT)
Prior art keywords
dna
foetal
identification
sample
diagnostic method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2001/003092
Other languages
French (fr)
Other versions
WO2002004672A2 (en
Inventor
Maj Anita Hulten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Simeg Ltd
Original Assignee
Simeg Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simeg Ltd filed Critical Simeg Ltd
Priority to EP01947676A priority Critical patent/EP1301630B1/en
Priority to HK04102885.0A priority patent/HK1060156B/en
Priority to AU2001269323A priority patent/AU2001269323B2/en
Priority to JP2002509525A priority patent/JP2004502466A/en
Priority to CA002414986A priority patent/CA2414986A1/en
Priority to US10/332,533 priority patent/US7083924B2/en
Priority to AU6932301A priority patent/AU6932301A/en
Priority to DE60126090T priority patent/DE60126090D1/en
Publication of WO2002004672A2 publication Critical patent/WO2002004672A2/en
Publication of WO2002004672A3 publication Critical patent/WO2002004672A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for the identification of foetal DNA in a maternal DNA-containing sample such as a blood or vaginal sample, said method comprising (a) isolating DNA from said sample, (b) subjecting said DNA to exonucleolytic digestion by an enzyme so as to remove end regions of each DNA molecule, and (c) detecting the presence of a DNA sequence remaining in foetal DNA but absent form maternal DNA as a result of said digestion process. Once identified, the foetal DNA can be subject to diagnosis for example to detect chromosomal /DNA abnormalities, including in particular aneuploides such as foetal trisomy 21.
PCT/GB2001/003092 2000-07-10 2001-07-09 Diagnostic method for the identification of foetal dna in a maternal sample Ceased WO2002004672A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP01947676A EP1301630B1 (en) 2000-07-10 2001-07-09 Diagnostic method for the identification of foetal dna in a maternal sample
HK04102885.0A HK1060156B (en) 2000-07-10 2001-07-09 Diagnostic method for the identification of foetal dna in a maternal sample
AU2001269323A AU2001269323B2 (en) 2000-07-10 2001-07-09 Diagnostic method for the indentification of foetal DNA in a maternal sample
JP2002509525A JP2004502466A (en) 2000-07-10 2001-07-09 Diagnosis method
CA002414986A CA2414986A1 (en) 2000-07-10 2001-07-09 Diagnostic method for the identification of foetal dna in a maternal sample
US10/332,533 US7083924B2 (en) 2000-07-10 2001-07-09 Diagnostic method for the identification of foetal DNA in a material sample
AU6932301A AU6932301A (en) 2000-07-10 2001-07-09 Diagnostic method
DE60126090T DE60126090D1 (en) 2000-07-10 2001-07-09 DIAGNOSTIC METHOD FOR THE IDENTIFICATION OF FETAL DNA IN A MATERNAL SAMPLE

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0016742.9 2000-07-10
GBGB0016742.9A GB0016742D0 (en) 2000-07-10 2000-07-10 Diagnostic method

Publications (2)

Publication Number Publication Date
WO2002004672A2 WO2002004672A2 (en) 2002-01-17
WO2002004672A3 true WO2002004672A3 (en) 2002-09-06

Family

ID=9895241

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/003092 Ceased WO2002004672A2 (en) 2000-07-10 2001-07-09 Diagnostic method for the identification of foetal dna in a maternal sample

Country Status (9)

Country Link
EP (1) EP1301630B1 (en)
JP (1) JP2004502466A (en)
CN (1) CN100558908C (en)
AT (1) ATE351923T1 (en)
AU (2) AU2001269323B2 (en)
CA (1) CA2414986A1 (en)
DE (1) DE60126090D1 (en)
GB (1) GB0016742D0 (en)
WO (1) WO2002004672A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332277B2 (en) 2002-03-01 2008-02-19 Ravgen, Inc. Methods for detection of genetic disorders
US7442506B2 (en) 2002-05-08 2008-10-28 Ravgen, Inc. Methods for detection of genetic disorders
US9163282B2 (en) 2010-05-18 2015-10-20 Natera, Inc. Methods for non-invasive prenatal ploidy calling

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ535044A (en) 2002-03-01 2008-12-24 Ravgen Inc Non-invasive method to determine the genetic sequence of foetal DNA from a sample from a pregnant female thereby detecting any alternation in gene sequence as compared with the wild type sequence
GB0214842D0 (en) * 2002-06-27 2002-08-07 Simeg Ltd Diagnostic method
AU2003268333A1 (en) * 2003-02-28 2004-09-28 Ravgen, Inc. Methods for detection of genetic disorders
WO2004078999A1 (en) * 2003-03-05 2004-09-16 Genetic Technologies Limited Identification of fetal dna and fetal cell markers in maternal plasma or serum
US20100216153A1 (en) * 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
US7645576B2 (en) * 2005-03-18 2010-01-12 The Chinese University Of Hong Kong Method for the detection of chromosomal aneuploidies
CN105039313B (en) 2005-06-23 2018-10-23 科因股份有限公司 For the high throughput identification of polymorphism and the strategy of detection
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US10081839B2 (en) 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10083273B2 (en) 2005-07-29 2018-09-25 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10316364B2 (en) 2005-09-29 2019-06-11 Keygene N.V. Method for identifying the source of an amplicon
CA2910861C (en) 2005-09-29 2018-08-07 Michael Josephus Theresia Van Eijk High throughput screening of mutagenized populations
EP3599609A1 (en) * 2005-11-26 2020-01-29 Natera, Inc. System and method for cleaning noisy genetic data and using data to make predictions
CN101421410A (en) * 2006-03-06 2009-04-29 纽约市哥伦比亚大学托管会 Specific amplification of fetal DNA sequences from a mixed, fetal-maternal source
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
EP2548972A1 (en) * 2006-06-14 2013-01-23 Verinata Health, Inc Methods for the diagnosis of fetal abnormalities
US12180549B2 (en) 2007-07-23 2024-12-31 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using genomic sequencing
HUE061020T2 (en) 2007-07-23 2023-05-28 Univ Hong Kong Chinese Determining a nucleic acid sequence imbalance
US20110183338A1 (en) * 2008-01-30 2011-07-28 Novartis Vaccines And Diagnostics, Inc. Two stage enrichment of cell-free fetal dna in maternal plasma
US20110178719A1 (en) 2008-08-04 2011-07-21 Gene Security Network, Inc. Methods for Allele Calling and Ploidy Calling
EP2473638B1 (en) 2009-09-30 2017-08-09 Natera, Inc. Methods for non-invasive prenatal ploidy calling
EA034241B1 (en) 2009-11-06 2020-01-21 Те Чайниз Юниверсити Ов Гонконг Method for performing prenatal diagnosis of a sequence imbalance
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US8825412B2 (en) 2010-05-18 2014-09-02 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12545960B2 (en) 2010-05-18 2026-02-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
EP2656263B1 (en) 2010-12-22 2019-11-06 Natera, Inc. Methods for non-invasive prenatal paternity testing
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
US9499870B2 (en) 2013-09-27 2016-11-22 Natera, Inc. Cell free DNA diagnostic testing standards
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
CN113774132A (en) 2014-04-21 2021-12-10 纳特拉公司 Detection of mutations and ploidy in chromosomal segments
US20180173846A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
CA2956208C (en) 2014-07-25 2025-07-08 University Of Washington Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
DK3294906T3 (en) 2015-05-11 2024-08-05 Natera Inc Methods for determining ploidy
DK3443119T3 (en) 2016-04-15 2022-05-23 Natera Inc Method for determining lung cancer
WO2018067517A1 (en) 2016-10-04 2018-04-12 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
WO2018156418A1 (en) 2017-02-21 2018-08-30 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
WO2019118926A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
AU2019205809A1 (en) * 2018-01-08 2020-08-13 Cradle Genomics, Inc. Methods and kits for nucleic acid isolation
WO2019161244A1 (en) 2018-02-15 2019-08-22 Natera, Inc. Methods for isolating nucleic acids with size selection
DK3781714T3 (en) 2018-04-14 2026-03-30 Natera Inc METHODS FOR CANCER DETECTION AND MONITORING BY PERSONAL DETECTION OF CIRCULATING TUMOR DNA
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
EP3980559A1 (en) 2019-06-06 2022-04-13 Natera, Inc. Methods for detecting immune cell dna and monitoring immune system

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430402A2 (en) * 1989-12-01 1991-06-05 The Regents Of The University Of California Methods and compositions for chromosome-specific staining
WO1994002646A1 (en) * 1992-07-17 1994-02-03 Aprogenex Inc. Enriching and identyfying fetal cells in maternal blood for in situ hybridization
WO1998039474A1 (en) * 1997-03-04 1998-09-11 Isis Innovation Limited Non-invasive prenatal diagnosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009784D0 (en) * 2000-04-20 2000-06-07 Simeg Limited Methods for clinical diagnosis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430402A2 (en) * 1989-12-01 1991-06-05 The Regents Of The University Of California Methods and compositions for chromosome-specific staining
WO1994002646A1 (en) * 1992-07-17 1994-02-03 Aprogenex Inc. Enriching and identyfying fetal cells in maternal blood for in situ hybridization
WO1998039474A1 (en) * 1997-03-04 1998-09-11 Isis Innovation Limited Non-invasive prenatal diagnosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
IWAMA HIROSHI ET AL: "Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals.", HUMAN GENETICS, vol. 102, no. 4, April 1998 (1998-04-01), pages 397 - 402, XP002200863, ISSN: 0340-6717 *
YOUNGREN KJELL ET AL: "Synchrony in telomere length of the human fetus.", HUMAN GENETICS, vol. 102, no. 6, June 1998 (1998-06-01), pages 640 - 643, XP002200862, ISSN: 0340-6717 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332277B2 (en) 2002-03-01 2008-02-19 Ravgen, Inc. Methods for detection of genetic disorders
US7598060B2 (en) 2002-03-01 2009-10-06 Ravgen, Inc. Rapid analysis of variations in a genome
US7442506B2 (en) 2002-05-08 2008-10-28 Ravgen, Inc. Methods for detection of genetic disorders
US9163282B2 (en) 2010-05-18 2015-10-20 Natera, Inc. Methods for non-invasive prenatal ploidy calling

Also Published As

Publication number Publication date
EP1301630B1 (en) 2007-01-17
WO2002004672A2 (en) 2002-01-17
CA2414986A1 (en) 2002-01-17
DE60126090D1 (en) 2007-03-08
CN1452665A (en) 2003-10-29
GB0016742D0 (en) 2000-08-30
JP2004502466A (en) 2004-01-29
ATE351923T1 (en) 2007-02-15
AU2001269323B2 (en) 2006-08-03
AU6932301A (en) 2002-01-21
EP1301630A2 (en) 2003-04-16
CN100558908C (en) 2009-11-11
HK1060156A1 (en) 2004-07-30

Similar Documents

Publication Publication Date Title
GB0016742D0 (en) Diagnostic method
WO2001081626A3 (en) Methods for clinical diagnosis
WO2000055368A3 (en) Probe/mobility modifier complexes for multiplex nucleic acid detection
WO2000077260A8 (en) Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms
EP1201771A3 (en) Detection and identification of human papillomavirus by PCR and type-specific reverse hybridization
AU7222698A (en) Method of preparing a standard diagnostic gene transcript pattern
EP0848067A3 (en) Computer-aided techniques for analyzing biological sequences
WO2002068685A3 (en) Diagnostic test for the detection of chromosomal abnormalities in a fetus
EP1088899A3 (en) Simultaneous detection, identification and differentiation of Eubacterial taxa using a hybridization assay
WO2003087297A3 (en) Infectious disease microarray
DE69814639D1 (en) NON-INVASIVE PRENATAL DIAGNOSIS
BR9507960A (en) Process probes and kits for detecting mycobacterial nucleic acids in biological samples
WO2005023091A3 (en) Method for non-invasive prenatal diagnosis
MXPA02006145A (en) Method for isolation of rna from formalinfixed paraffinembedded tissue specimens.
EP1164203A3 (en) DNA Diagnostics based on mass spectrometry
WO2001057275A3 (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
WO1998028444A3 (en) Customized oligonucleotide microchips as multiple biosensors
FR2685346B1 (en) PROCESS FOR THE PREPARATION OF DOUBLE-STRANDED RNA, AND ITS APPLICATIONS.
WO2006076047A3 (en) Electrocatalytic nucleic acid hybridization detection
WO2003066896A3 (en) Method for the detection of mutations
CA2462932A1 (en) Method for the detection of cytosine methylations in immobilized dna samples
EP3719182B1 (en) Method for constructing library of cell-free dnas in body fluids and application thereof
WO2005054516A3 (en) Peptide nucleic acid probes for analysis of certain staphylococcus species
AU6873196A (en) Extraction, amplification and sequential hybridization of fungal cell DNA and process for detection of fungal cells in clinical material
WO2005005952A3 (en) Electrocatalytic nucleic acid hybridization detection

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2414986

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001947676

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001269323

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 018153542

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 10332533

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001947676

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2001947676

Country of ref document: EP